Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Advanced Cancer 2Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Non-Muscle Invasive Bladder Neoplasms 1Melanoma 1Lymphoid Interstitial Pneumonia 1Laryngeal Diseases 1Endometrial Adenocarcinoma 1Carcinoma, Squamous Cell 1Advanced Gastric Cancer 1

Interventions

Platinum 2Gemcitabine 2Gefitinib 2Cisplatin 2Cetuximab 21,2-diaminocyclohexaneplatinum II citrate 2vandetanib 1temsirolimus 1linrodostat 1ficlatuzumab 1durvalumab 1cediranib 1adavosertib 1Trioxsalen 1Soybean Proteins 1Sirolimus 1Radiotherapy, Intensity-Modulated 1Phototherapy 1Photochemotherapy 1Pemetrexed 1Paclitaxel 1Nivolumab 1Immunohistochemistry 1Dihematoporphyrin Ether 1Carboplatin 1Biopsy 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Lymphoid Interstitial Pneumonia × linrodostat × Clear all
NCT03854032 2025-06-06

Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and Neck

Thomas Jefferson University

Phase 2 Active not recruiting
45 enrolled
Head & Neck

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Laryngeal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡